News

Kennedy, Jr. doubled down on his support for non-pharmaceutical health treatments during a recent podcast appearance, saying, ...
After 25 years, a pair of doctors at Memorial Sloan Kettering studying stem-cell therapy are optimistic. Former Biden press ...
This first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient ...
Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...
Treatment for Parkinson's focuses on managing its many symptoms, as there is no cure. But a new stem cell therapy developed at Memorial Sloan Kettering Cancer Center for advanced Parkinson's is ...
Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein ...
An estimated 8,000 people in Singapore live with the disease. Read more at straitstimes.com. Read more at straitstimes.com.
XellSmart has completed multiple cases of iPSC-derived dopaminergic neural progenitor cell therapy for patients with ...
A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...
The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.
Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical ...